BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Topics
»
Regulatory
» EMA
EMA
RSS
EMA accepts for review brexpiprazole MAA for schizophrenia in adults
March 24, 2017
EMA gives positive scientific advice on approval pathway for Actinium's Iomab-B
March 22, 2017
EMA committee agrees on pediatric investigation plan for Macrilen
March 8, 2017
FDA and EMA accept for filing ertugliflozin submissions
March 7, 2017
European Commission approves Ledaga for mycosis fungoides-type CTCL
March 7, 2017
EMA grants orphan drug designation to Resolaris for limb girdle muscular dystrophy
March 6, 2017
EMA grants SPK-9001 access to PRIME program for hemophilia B
March 6, 2017
EMA grants PRIME access to givosiran for acute hepatic porphyrias
March 2, 2017
EMA committee hands down positive opinion for 8-week regimen of Viekirax + Exviera
March 1, 2017
EMA committee hands down positive opinion for Varuby
Feb. 27, 2017
Previous
1
2
…
44
45
46
47
48
49
50
51
52
…
158
159
Next
RSS